ALETHEA CAPITAL MANAGEMENT, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1549408 MERCER ISLAND, WA

Position in RNA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$585,044

New position

Shares Held

43,758

first reported quarter

Ownership

0.256%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ALETHEA CAPITAL MANAGEMENT, LLC holds $122,852,928 across 4 Biotechnology names. RNA ranks #3 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	649,114	$109,713,248
2	KURA	Kura Oncology, Inc.	1,529,369	$12,433,769
3	RNA	Atrium Therapeutics, Inc. This page	43,758	$585,044
4	IMRX	Immuneering Corp	22,935	$120,867

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$585,044	43,758	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.